Ann Arbor, MI, United States of America

Hollis D Showalter

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Warner-Lambert Company. Active years: 1986.

USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1986

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Hollis D Showalter

Introduction

Hollis D Showalter is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of chemistry, particularly in the development of compounds with various therapeutic applications. His work has implications in antibacterial, antifungal, antileukaemic, and antitumor activities.

Latest Patents

One of his key patents is titled "Process for preparing substituted anthra[1,9-cd]pyrazol-6(2H)-ones." This patent discloses an improved process for synthesizing anthra[1,9-cd]pyrazol-6(2H)-ones from 1,4-dichloro-5,8-disubstituted-9,10-anthracenediones and a hydrazine. The compounds produced through this process have shown promising biological activities.

Career Highlights

Throughout his career, Hollis D Showalter has worked with prominent organizations, including Warner-Lambert Company and the University of Michigan. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

He has collaborated with notable colleagues such as Judith L Johnson and Nicholas J Donato, further enhancing the impact of his work in the field.

Conclusion

Hollis D Showalter's innovative contributions to chemistry and his patent on anthra[1,9-cd]pyrazol-6(2H)-ones highlight his role as a significant inventor. His work continues to influence research and development in therapeutic applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…